Genetics of Liver Function
The liver is the body's primary metabolic and detoxification organ, responsible for drug metabolism, lipid synthesis, glucose regulation, and protein production. Genetic variants in liver function genes may influence metabolic capacity and medication handling in chronic illness.
This page is for educational and informational purposes only. Not a diagnostic tool. Always consult a qualified healthcare provider.
What is Liver Function?
The liver performs over 500 essential functions including drug detoxification (CYP450 enzymes), lipid and carbohydrate metabolism (PCSK9, HMGCR, G6PC), coagulation factor synthesis, bile acid production, and inflammatory protein secretion (CRP, fibrinogen). COVID-19 can cause hepatic inflammation and dysfunction, and some Long COVID patients report persistent liver enzyme elevations. Genetic variants in hepatic enzymes and transporters may modify liver vulnerability to inflammatory insult and the efficiency of metabolic and detoxification functions during chronic illness.
Biological pathways commonly discussed in relation to Liver Function
Research into Liver Function and Hepatic Metabolism has highlighted several biological pathways that may be relevant. Genetic variants within these pathways may influence individual susceptibility, symptom severity, or the trajectory of the condition.
Hepatic Detoxification
CYP3A4/5, CYP2C9, and Phase II enzymes in hepatocytes metabolise drugs and endogenous metabolites. Variants affecting hepatic CYP activity underlie most pharmacogenomic drug response differences.
Bile Acid Metabolism
CYP7A1 (cholesterol 7-alpha hydroxylase) is the rate-limiting enzyme in bile acid synthesis from cholesterol. Variants affect cholesterol metabolism and enterohepatic circulation.
Hepatic Lipid
PCSK9, LDLR, HMGCR, and APOB regulate hepatic cholesterol and triglyceride metabolism. PNPLA3 Ile148Met is the strongest genetic variant for non-alcoholic fatty liver disease risk.
Liver Inflammation
COVID-19 can trigger hepatic inflammation via ACE2-expressing hepatocytes and cholangiocytes. IL-6, IL-1, and TNF-driven hepatic acute phase responses elevate CRP, fibrinogen, and coagulation factors.
Key genes studied in relation to Liver Function
The following genes have been studied in relation to Liver Function and Hepatic Metabolism. These genes span the biological pathways most commonly discussed in this area of research.
Genetic variants commonly discussed
The following genetic variants (SNPs) are found in genes that have been studied in relation to Liver Function. Each variant represents a position in the genome where individuals may carry different alleles.
15 variants total across genes studied in relation to Liver Function.
How personal DNA data may provide educational insights
Consumer DNA files from 23andMe, AncestryDNA, and MyHeritage contain raw SNP data. When you upload your file to ChronicDNA, the analysis engine checks your genotype against a curated panel of 80+ genes selected for their relevance to Long COVID, ME/CFS, and connected biological pathways - some of which may relate to areas such as Liver Function.
This is not a diagnostic service. Genetic variants do not determine whether you have Liver Function, nor do they predict your clinical outcomes. The report is educational - it explains which variants you carry, what the research says about them, and how they fit into the biological pathways most relevant to chronic illness. All results should be discussed with a qualified healthcare provider.
Related conditions and pathways
Liver Function shares biological pathways and genetic associations with the following related conditions and areas of research.
Frequently asked questions
How does COVID-19 affect the liver?
SARS-CoV-2 can infect hepatocytes and cholangiocytes via ACE2, and COVID-19 is associated with elevated liver enzymes in 14–53% of hospitalised patients. Long COVID may involve persistent low-grade hepatic inflammation in some patients. Genetic variants affecting liver vulnerability to inflammatory insult may modify these outcomes.
What is PNPLA3 and why is it the key NAFLD gene?
PNPLA3 Ile148Met (rs738409) is the strongest common genetic variant associated with non-alcoholic fatty liver disease, steatohepatitis, and liver fibrosis risk. The Met allele impairs triglyceride hydrolysis in hepatocytes, promoting lipid accumulation. It is present in approximately 25% of Europeans as a heterozygote.
Which liver function genes are most clinically relevant?
Key genes include PNPLA3, TM6SF2, PCSK9, LDLR, CYP3A4, CYP2C9, SLCO1B1, ABCC2, UGT1A1, and G6PD. These cover fatty liver risk, cholesterol regulation, drug metabolism, and bilirubin processing.
How do liver genetics relate to drug sensitivity in Long COVID?
Hepatic CYP450 enzyme variants (CYP3A4, CYP2C9, CYP2D6) determine how quickly medications are metabolised. Impaired hepatic function during illness can compound pharmacogenomic effects, potentially increasing drug sensitivity in Long COVID patients.
Explore DNA insights
If you already have DNA data from 23andMe, AncestryDNA, or MyHeritage, upload your raw file to ChronicDNA and receive a personalised educational report covering genes studied in relation to Liver Function and connected biological pathways.
Get Your Personalised DNA ReportInformational and educational only · Not a diagnostic tool · GDPR compliant
8 genes · 15 variants analysed in relation to Liver Function